Zyprexa® Relprevv™ Patient Care Program
NCT01088386 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 4000
Last updated 2026-01-28
Summary
The goal of the Zyprexa Relprevv Patient Care Program is to mitigate the risk of negative outcomes associated with Zyprexa Relprevv post-injection delirium/sedation syndrome (PDSS).
Conditions
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Call 1-877-CTLILLY(1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT - 5 hours, EST) · Eli Lilly and Company
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-03-03
- Primary Completion
- 2026-06-30
- Completion
- 2026-06-30
Countries
- United States
Study Locations
More Related Trials
-
Clinical Trial Evaluating the Efficacy, Safety, and Tolerability of Cariprazine in a Dose-Reduction Paradigm in the Prevention of Relapse in Participants With Schizophrenia
NCT03593213 ·Status: TERMINATED ·Phase: PHASE3
-
The Effect of Switching to Aripiprazole on Heart Health in Overweight and Obese Patients With Schizophrenia
NCT00222833 ·Status: COMPLETED ·Phase: PHASE4
-
A Safety and PK Study of Injectable Risperidone-SABER and the DosePro Delivery System in Patients With Schizophrenia
NCT01592110 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Aripiprazole Lauroxil in Subjects With Schizophrenia or Schizoaffective Disorder
NCT02636842 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of the Efficacy and Safety of Risperidone Injections Given Once a Month to Adults With Schizophrenia or Schizoaffective Disorder
NCT00236353 ·Status: COMPLETED ·Phase: PHASE3
-
Long-Acting Injectable Risperidone in the Treatment of Schizophrenia
NCT00132314 ·Status: COMPLETED ·Phase: PHASE3
-
Ziprasidone for Improving Insulin Sensitivity in People With Schizophrenia Who Are at Risk for Diabetes
NCT00338949 ·Status: COMPLETED ·Phase: PHASE4
-
Safety And Tolerability Of Ziprasidone In Adolescents With Schizophrenia
NCT00265382 ·Status: TERMINATED ·Phase: PHASE3
-
Efficacy Study of Early Onset of Antipsychotic Drug Action in Schizophrenia
NCT00337662 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia
NCT03503318 ·Status: COMPLETED ·Phase: PHASE3
-
RP5063 in Subjects With Schizophrenia or Schizoaffective Disorder
NCT01490086 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Efficacy and Safety of Ziprasidone and Aripiprazole for the Treatment fo Schizophrenia or Schizoaffective Disorder in Hospitalized Patients
NCT00634348 ·Status: COMPLETED ·Phase: PHASE4
-
Randomized, Double-blind, Placebo Controlled, Multi-center and Tolerability of RBP-7000 in Schizophrenia Patients
NCT02109562 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia
NCT03893825 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Study to Assess Treatment & Outcomes Data in Patients Receiving Long-Acting Injectable Risperidone
NCT00774085 ·Status: COMPLETED
-
Safety and Tolerability Study of Single-dose Administration of Brexpiprazole in Adult Subjects With Schizophrenia
NCT02968121 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and PK Trial With Injectable ZX003 (Risperidone-SABER®) Compared to Risperdal® Consta® in Stable Schizophrenia
NCT02411526 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of How Long it Takes a Patient to Relapse After Switching From an Oral Antipsychotic to One of Two Doses of Long-acting Risperidone Injections in Patients With Schizophrenia or Schizoaffective Disorder
NCT00297388 ·Status: COMPLETED ·Phase: PHASE3
-
A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression
NCT00208156 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Study Comparing Aripiprazole Once Monthly With Standard of Care Medication in Outpatients With Schizophrenia
NCT02282085 ·Status: UNKNOWN ·Phase: PHASE4
-
A Long Term Study of Safety for Long Acting Injectable Risperidone in Patients With Schizophrenia or Schizoaffective Disorder.
NCT00558298 ·Status: COMPLETED ·Phase: PHASE3
-
A Pilot Study of the Use of Risperidone Long Acting Injectable in the Treatment of Patients With Recent Onset Psychosis
NCT00216580 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Dose Levels, Safety, and Drug Levels of Single KarXT Intramuscular Injection in Participants With Schizophrenia
NCT07061288 ·Status: RECRUITING ·Phase: PHASE1
-
Improving Diabetes Risk Factors in Persons With Schizophrenia or Bipolar Disorder by Switching to Ziprasidone
NCT00538642 ·Status: COMPLETED ·Phase: NA
-
PK, Safety, and Tolerability Study of RBP-7000 of Different Molecular Weight Polymer in Subjects With Schizophrenia
NCT02687984 ·Status: COMPLETED ·Phase: PHASE1